Can acotinib treat esophageal cancer?

Currently, acotinib (Acalabrutinib) is mainly used to treat B cell lymphoma, especially chronic lymphocytic leukemia (CLL). It is a BTK inhibitor that mainly targets malignant diseases of the blood system. Acotinib is not a standard treatment for esophageal cancer. Esophageal cancer usually requires comprehensive treatment, including surgery, radiotherapy, chemotherapy, etc. Treatment decisions for esophageal cancer should be made by professional doctors based on the patient's specific circumstances. If you or someone you know has esophageal cancer, it is recommended to consult a specialist for the most accurate diagnosis and treatment recommendations.